These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 39186873)
21. Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity. Shamim M; Nanjappa SG; Singh A; Plisch EH; LeBlanc SE; Walent J; Svaren J; Seroogy C; Suresh M J Immunol; 2007 Dec; 179(11):7233-43. PubMed ID: 18025165 [TBL] [Abstract][Full Text] [Related]
22. CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells. Niiro H; Jabbarzadeh-Tabrizi S; Kikushige Y; Shima T; Noda K; Ota S; Tsuzuki H; Inoue Y; Arinobu Y; Iwasaki H; Shimoda S; Baba E; Tsukamoto H; Horiuchi T; Taniyama T; Akashi K Blood; 2012 Mar; 119(10):2263-73. PubMed ID: 22262777 [TBL] [Abstract][Full Text] [Related]
23. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity. Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434 [TBL] [Abstract][Full Text] [Related]
24. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes. Thien CB; Bowtell DD; Langdon WY J Immunol; 1999 Jun; 162(12):7133-9. PubMed ID: 10358158 [TBL] [Abstract][Full Text] [Related]
25. An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells. Zha Y; Gajewski TF Cell Immunol; 2007 Jun; 247(2):95-102. PubMed ID: 17897636 [TBL] [Abstract][Full Text] [Related]
26. Crk adaptor proteins regulate CD3ζ chain phosphorylation and TCR/CD3 down-modulation in activated T cells. Dong G; Kalifa R; Nath PR; Babichev Y; Gelkop S; Isakov N Cell Signal; 2017 Aug; 36():117-126. PubMed ID: 28465009 [TBL] [Abstract][Full Text] [Related]
27. Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) pathway initiated by T cell antigen receptor (TCRγδ) activation is required to overcome inhibition by ubiquitin ligase Cbl-b during γδT cell cytotoxicity. Yin S; Zhang J; Mao Y; Hu Y; Cui L; Kang N; He W J Biol Chem; 2013 Sep; 288(37):26448-62. PubMed ID: 23897818 [TBL] [Abstract][Full Text] [Related]
28. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine. Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769 [TBL] [Abstract][Full Text] [Related]
29. Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy. Kumar S; Naqvi RA; Khanna N; Rao DN Mol Immunol; 2011 May; 48(9-10):1178-90. PubMed ID: 21453975 [TBL] [Abstract][Full Text] [Related]
30. CBAP promotes thymocyte negative selection by facilitating T-cell receptor proximal signaling. Ho KC; Chiang YJ; Lai AC; Liao NS; Chang YJ; Yang-Yen HF; Yen JJ Cell Death Dis; 2014 Nov; 5(11):e1518. PubMed ID: 25393474 [TBL] [Abstract][Full Text] [Related]
31. TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation. Lehnert C; Weiswange M; Jeremias I; Bayer C; Grunert M; Debatin KM; Strauss G J Immunol; 2014 Oct; 193(8):4021-31. PubMed ID: 25217163 [TBL] [Abstract][Full Text] [Related]
32. Silencing the expression of Cbl-b enhances the immune activation of T lymphocytes against RM-1 prostate cancer cells in vitro. Zhou SK; Chen WH; Shi ZD; Wang SP; Li L; Wen XF; Wang YM J Chin Med Assoc; 2014 Dec; 77(12):630-6. PubMed ID: 25249301 [TBL] [Abstract][Full Text] [Related]
33. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells. Qiao G; Zhao Y; Li Z; Tang PQ; Langdon WY; Yang T; Zhang J J Immunol; 2013 Jul; 191(2):632-9. PubMed ID: 23749633 [TBL] [Abstract][Full Text] [Related]
34. ZAP-70 Regulates Autoimmune Arthritis via Alterations in T Cell Activation and Apoptosis. Kugyelka R; Prenek L; Olasz K; Kohl Z; Botz B; Glant TT; Berki T; Boldizsár F Cells; 2019 May; 8(5):. PubMed ID: 31137740 [TBL] [Abstract][Full Text] [Related]
35. Interactions of Cbl with Grb2 and phosphatidylinositol 3'-kinase in activated Jurkat cells. Meisner H; Conway BR; Hartley D; Czech MP Mol Cell Biol; 1995 Jul; 15(7):3571-8. PubMed ID: 7791764 [TBL] [Abstract][Full Text] [Related]
36. Co-recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR-induced ubiquitylation. Voisinne G; García-Blesa A; Chaoui K; Fiore F; Bergot E; Girard L; Malissen M; Burlet-Schiltz O; Gonzalez de Peredo A; Malissen B; Roncagalli R Mol Syst Biol; 2016 Jul; 12(7):876. PubMed ID: 27474268 [TBL] [Abstract][Full Text] [Related]
37. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells. van Leeuwen JE; Paik PK; Samelson LE Mol Cell Biol; 1999 Oct; 19(10):6652-64. PubMed ID: 10490604 [TBL] [Abstract][Full Text] [Related]
38. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway. Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467 [TBL] [Abstract][Full Text] [Related]
39. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation. Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985 [TBL] [Abstract][Full Text] [Related]
40. Src-like adaptor protein regulates TCR expression on thymocytes by linking the ubiquitin ligase c-Cbl to the TCR complex. Myers MD; Sosinowski T; Dragone LL; White C; Band H; Gu H; Weiss A Nat Immunol; 2006 Jan; 7(1):57-66. PubMed ID: 16327786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]